Back

Sex differences in the treatment with statins after myocardial infarction in denmark: a time-trend study utilising national registries

29 August 2026 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Myocardial infarction in women: presentation, treatment, and mortality Cardiovascular Disease in Women ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Miss Anna Andersen

(Denmark)

6 More presentations in this session

Presentation thumbnail
Sex differences in in-hospital mortality and revascularisation among young adults with acute myocardial infarction: evidence of an ischaemic paradox from a national cohort (2018–2022)
Doctor V. Polana (Brooklyn, US)
Abstract
Presentation thumbnail
Persistent sex disparities in presentation, invasive management, and in-hospital mortality in patients with acute myocardial infarction: an 11-year national cohort study
Associate Professor P. Ibrahimi (Pristina, XK)
Abstract
Presentation thumbnail
Real-world use of bempedoic acid in women and men: pooled 1-year follow-up data from the observational, prospective, real-world MILOS study in Austria, Belgium, Germany, Italy, and the United Kingdom
Professor I. Gouni-Berthold (Cologne, DE)
Abstract
Presentation thumbnail
Age-stratified LDL trends and lipid-lowering therapy gaps in women undergoing cardiac catheterization
Doctor V. Raona (IT)
Abstract
Presentation thumbnail
Gender-specific LDL-c target windows in acute myocardial infarction patients with liver dysfunction: a real-world cohort analysis
Doctor R. Guo (Tianjin, CN)
Abstract

Access the full session

Session thumbnail
Myocardial infarction in women: presentation, treatment, and mortality

The Event

Event poster

ESC Congress 2026

29 August 2026 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Gender disparities in management and treatment in acute myocardial infarction - a german nationwide real-life analysis
1 September 2020
thumbnail
Congress Presentation
The association between long-term statin use and cataract in both primary and secondary prevention of cardiovascular disease - a nationwide, cohort study on 597,605 cataract patients
26 August 2022
thumbnail
Congress Presentation
Time trends in risk factor control and use of secondary preventive medication among patients with myocardial infarction attending cardiac rehabilitation: data from the SWEDEHEART registry 2006-2017
30 August 2020
thumbnail
Congress Presentation
Statins for primary prevention among elderly men and women.
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources